ATE188994T1 - Methoden zur trans-destabilisierung von spezifischen proteinen in vivo - Google Patents

Methoden zur trans-destabilisierung von spezifischen proteinen in vivo

Info

Publication number
ATE188994T1
ATE188994T1 AT91910688T AT91910688T ATE188994T1 AT E188994 T1 ATE188994 T1 AT E188994T1 AT 91910688 T AT91910688 T AT 91910688T AT 91910688 T AT91910688 T AT 91910688T AT E188994 T1 ATE188994 T1 AT E188994T1
Authority
AT
Austria
Prior art keywords
protein
peptide
vivo
interest
methods
Prior art date
Application number
AT91910688T
Other languages
English (en)
Inventor
Alexander Varshavsky
Erica S Johnson
David K Gonda
Mark Hochstrasser
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Application granted granted Critical
Publication of ATE188994T1 publication Critical patent/ATE188994T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/95—Fusion polypeptide containing a motif/fusion for degradation (ubiquitin fusions, PEST sequence)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Accessory Devices And Overall Control Thereof (AREA)
  • Control Or Security For Electrophotography (AREA)
  • Facsimiles In General (AREA)
AT91910688T 1990-05-17 1991-05-14 Methoden zur trans-destabilisierung von spezifischen proteinen in vivo ATE188994T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/525,150 US5122463A (en) 1990-05-17 1990-05-17 Methods for trans-destabilization of specific proteins in vivo and dna molecules useful therefor
PCT/US1991/003366 WO1991018096A1 (en) 1990-05-17 1991-05-14 Methods for trans-destabilization of specific proteins in vivo

Publications (1)

Publication Number Publication Date
ATE188994T1 true ATE188994T1 (de) 2000-02-15

Family

ID=24092138

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91910688T ATE188994T1 (de) 1990-05-17 1991-05-14 Methoden zur trans-destabilisierung von spezifischen proteinen in vivo

Country Status (10)

Country Link
US (1) US5122463A (de)
EP (1) EP0532587B1 (de)
JP (1) JP3406314B2 (de)
AT (1) ATE188994T1 (de)
CA (1) CA2079584C (de)
DE (1) DE69131929T2 (de)
DK (1) DK0532587T3 (de)
ES (1) ES2140390T3 (de)
GR (1) GR3033094T3 (de)
WO (1) WO1991018096A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6068994A (en) * 1989-08-07 2000-05-30 Chiron Corporation Ubiquitin expression system
US5565352A (en) * 1993-11-24 1996-10-15 Arch Development Corporation Deubiquitinating enzyme: compositions and methods
US5538862A (en) * 1994-02-04 1996-07-23 California Institute Of Technology Heat-inducible N-degron module
US5763212A (en) * 1994-02-04 1998-06-09 California Institute Of Technology Inhibiting degradation of a degron-bearing protein
US6551618B2 (en) 1994-03-15 2003-04-22 University Of Birmingham Compositions and methods for delivery of agents for neuronal regeneration and survival
WO1996026733A1 (en) * 1995-03-01 1996-09-06 Alexander Varshavsky Codominance-mediated toxins
US5932425A (en) * 1997-02-18 1999-08-03 Signal Pharmaceuticals, Inc. Compositions and methods for modulating cellular NF-κB activation
US7157418B1 (en) 1998-07-22 2007-01-02 Osprey Pharmaceuticals, Ltd. Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
US20030215421A1 (en) * 1999-07-21 2003-11-20 Mcdonald John R. Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
WO2000042185A1 (en) * 1999-01-11 2000-07-20 Mindset Biopharmaceuticals (Usa), Inc. Methods for regulating the stability of recombinant proteins and products useful therein
US6306663B1 (en) 1999-02-12 2001-10-23 Proteinex, Inc. Controlling protein levels in eucaryotic organisms
US7262005B1 (en) 2000-02-04 2007-08-28 Aurora Biosciences Corporation Methods of protein destabilization and uses thereof
EP1361892A4 (de) 2001-01-17 2004-10-13 Trubion Pharmaceuticals Inc Bindungsdomäne-immunglobulin-fusionsproteine
US7829084B2 (en) 2001-01-17 2010-11-09 Trubion Pharmaceuticals, Inc. Binding constructs and methods for use thereof
AUPR446801A0 (en) 2001-04-18 2001-05-17 University Of Queensland, The Novel compositions and uses therefor
DK1919954T3 (en) 2005-08-30 2017-01-30 Univ Miami Immune modulating tumor necrosis factor receptor (TNFR25) - agonists, antagonists and immunotoxins
US8173792B2 (en) 2007-02-09 2012-05-08 The Board Of Trustees Of The Leland Stanford Junior University Method for regulating protein function in cells using synthetic small molecules
WO2009049350A1 (en) * 2007-10-15 2009-04-23 The University Of Queensland Expression system for modulating an immune response
US8530636B2 (en) * 2008-05-07 2013-09-10 The Board Of Trustees Of The Leland Stanford Junior University Method for regulating protein function in cells in vivo using synthetic small molecules
AU2009320006A1 (en) 2008-10-30 2010-06-03 Peixuan Guo Membrane-integrated viral DNA-packaging motor protein connector biosensor for DNA sequencing and other uses
ES2586837T3 (es) 2009-08-03 2016-10-19 University Of Miami Método para la expansión in vivo de linfocitos T reguladores
US9795658B2 (en) 2010-04-20 2017-10-24 Admedus Vaccines Pty Ltd Expression system for modulating an immune response
US9212359B2 (en) 2011-06-23 2015-12-15 Sanford Jay Silverman Systems for induction of gene expression and protein depletion in yeast
EP2943253B1 (de) 2013-01-09 2021-10-20 University Of Miami Zusammensetzungen und verfahren zur regulierung regulatorischer t-zellen mit tl1a-ig-fusionsprotein und il-2
US11285191B2 (en) 2016-07-26 2022-03-29 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Immunostimulatory compositions and uses therefor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1266639A (en) * 1985-10-16 1990-03-13 Ronald E. Aleshire Cable-pulling system
US5132213A (en) * 1986-10-02 1992-07-21 Massachusetts Institute Of Technology Method for producing proteins and polypeptides using ubiquitin fusions
DE3731103C1 (de) * 1987-09-16 1988-11-24 Schoeller & Co Elektrotech Aus Tastenschaltern zusammengesetztes Tastenfeld

Also Published As

Publication number Publication date
JPH05506360A (ja) 1993-09-22
CA2079584C (en) 1999-04-13
DE69131929D1 (de) 2000-02-24
JP3406314B2 (ja) 2003-05-12
DK0532587T3 (da) 2000-04-17
GR3033094T3 (en) 2000-08-31
US5122463A (en) 1992-06-16
EP0532587B1 (de) 2000-01-19
EP0532587A1 (de) 1993-03-24
WO1991018096A1 (en) 1991-11-28
DE69131929T2 (de) 2000-08-17
ES2140390T3 (es) 2000-03-01
CA2079584A1 (en) 1991-11-18

Similar Documents

Publication Publication Date Title
DE69131929D1 (de) Methoden zur trans-destabilisierung von spezifischen proteinen in vivo
ATE352617T1 (de) Lösliche polypeptidfraktionen des lag-3-proteins; verfahren zur herstellung; therapeutische zusamensetzung; antiidiotypischer antikörper
ATE138102T1 (de) Verfahren zur herstellung von cysteinfreien peptiden
DE69128285D1 (de) Expression rekombinanter polypeptide mit verbesserter möglichkeit zur reinigung
ATE335078T1 (de) Überexpression von säugetier- und virusproteinen
DE69934967D1 (de) Verfahren zur verminderung der immunogenität von proteinen
DE69129865D1 (de) Osteogene peptide
DK3688A (da) Pankreatisk sekretorisk trypsininhibitor og varianter deraf fremstillet af en rekombinant vaert, fremgangsmaade, ekspressionsvektor og rekombinant vaert samt farmaceutisk anvendelse deraf
ES550943A0 (es) Un procedimiento para preparar una proteina de fusion derivada de la secuencia de aminoacidos de la preprorrelaxina humana.
SE8801701D0 (sv) Production technology based on enzymic method
DK610888A (da) Cardiodilatinfragmentet, fremgangsmaade til fremstilling deraf samt dets anvendelse
ATE253639T1 (de) Verfahren zur herstellung von peptiden
ATE432287T1 (de) Peptidfragmente mit den zelltod verhindernder aktivität
ATE290088T1 (de) Verfahren zur spaltung eines chimeren proteins mittels eines 'processing'-enzyms
DE3873273D1 (de) Verfahren zur selektiven spaltung von fusionsproteinen.
DE3852105D1 (de) Verfahren zur herstellung von aprotinin und aprotinin-homologen in hefe.
ATE122099T1 (de) Verfahren zur herstellung von c-terminalen alpha- amidierten peptiden.
ATE141645T1 (de) In vitro-behandlung von fusionsproteinen
DE59914155D1 (de) Neue peptidfragmente zur reinigung von proteinen
DE69613086D1 (de) Antigenen Peptide mit Glycinsubstitution
ATE103341T1 (de) Antikoerper gegen hochkonservierte aminosaeuresequenzen von immunogenen substanzen, verfahren zur herstellung dieser antikoerper, sowie deren verwendung in immunoassays.
Besada et al. Mass spectrometry in protein analysis.
ATE110775T1 (de) Verfahren zur herstellung von hirudin.
SE8803986D0 (sv) Method for sequencing peptides or proteins
EP1083497A4 (de) Verfahren zum schätzen von proteinfunktionen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee